Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 3
1978 2
1979 3
1984 1
1987 1
1994 2
1995 3
1998 1
1999 1
2000 1
2004 2
2007 1
2009 1
2010 1
2011 3
2012 4
2013 1
2015 1
2017 3
2018 1
2019 1
2020 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.
Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK, Jennings DM, Karakantza M, Al-Ismail S, Collins GP, McConnell S, Langton C, Al-Obaidi MJ, Oblak M, Salek S. Goswami P, et al. Among authors: al ismail s. Front Pharmacol. 2020 Sep 8;11:1308. doi: 10.3389/fphar.2020.01308. eCollection 2020. Front Pharmacol. 2020. PMID: 33013368 Free PMC article.
Immunophenotyping of normal lymphocytes.
Peters RE, al-Ismail S. Peters RE, et al. Among authors: al ismail s. Clin Lab Haematol. 1994 Mar;16(1):21-32. doi: 10.1111/j.1365-2257.1994.tb00384.x. Clin Lab Haematol. 1994. PMID: 8039343
MRONJ risk reduction pathway - 360 degree survey.
Muthukrishnan A, Al-Ismail S, Bertelli G, Browne P. Muthukrishnan A, et al. Among authors: al ismail s. Br Dent J. 2017 Mar 10;222(5):386-390. doi: 10.1038/sj.bdj.2017.225. Br Dent J. 2017. PMID: 28281587
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study.
Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK, Jennings DM, Karakantza M, Al-Ismail S, Collins GP, McConnell S, Langton C, Salek S. Goswami P, et al. Among authors: al ismail s. Ther Adv Hematol. 2020 Oct 7;11:2040620720955002. doi: 10.1177/2040620720955002. eCollection 2020. Ther Adv Hematol. 2020. PMID: 33101618 Free PMC article.
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.
Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK, Jennings DM, Karakantza M, Al-Ismail S, Collins GP, McConnell S, Langton C, Al-Obaidi MJ, Oblak M, Salek S. Goswami P, et al. Among authors: al ismail s. Front Pharmacol. 2020 Oct 20;11:571066. doi: 10.3389/fphar.2020.571066. eCollection 2020. Front Pharmacol. 2020. PMID: 33192513 Free PMC article.
Proceedings of Patient Reported Outcome Measure's (PROMs) Conference Oxford 2017: Advances in Patient Reported Outcomes Research : Oxford, UK. 8th June 2017.
Velikova G, Valderas JM, Potter C, Batchelder L, A’Court C, Baker M, Bostock J, Coulter A, Fitzpatrick R, Forder J, Fox D, Geneen L, Gibbons E, Jenkinson C, Jones K, Kelly L, Peters M, Mulhern B, Labeit A, Rowen D, Meadows K, Elliott J, Brazier J, Knowles E, Keetharuth A, Brazier J, Connell J, Carlton J, Buck LT, Ricketts T, Barkham M, Goswami P, Salek S, Ionova T, Oliva E, Fielding AK, Karakantza M, Al-Ismail S, Collins GP, McConnell S, Langton C, Jennings DM, Else R, Kell J, Ward H, Day S, Lumley E, Phillips P, Duncan R, Buckley-Woods H, Aber A, Jones G, Michaels J, Porter I, Gangannagaripalli J, Davey A, Ricci-Cabello I, Haywood K, Hansen ST, Valderas J, Roberts D, Gumber A, Podmore B, Hutchings A, van der Meulen J, Aggarwal A, Konan S, Price A, Jackson W, Bottomley N, Philiips M, Knightley-Day T, Beard D, Gibbons E, Fitzpatrick R, Greenhalgh J, Gooding K, Gibbons E, Valderas C, Wright J, Dalkin S, Meads D, Black N, Fawkes C, Froud R, Carnes D, Price A, Cook J, Dakin H, Smith J, Kang S, Beard D; The ACHE Study Team; Griffiths C, Guest E, Harcourt D, Murphy M, Hollinghurst S, Salisbury C, Carlton J, Elliott J, Rowen D, Gao A, Price A, Beard D, Lemanska A, Chen T, Dearnale… See abstract for full author list ➔ Velikova G, et al. Among authors: al ismail s. Health Qual Life Outcomes. 2017 Oct 5;15(Suppl 1):185. doi: 10.1186/s12955-017-0757-y. Health Qual Life Outcomes. 2017. PMID: 29035171 Free PMC article. No abstract available.
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK, Jennings DM, Karakantza M, Al-Ismail S, Lyness J, Collins GP, McConnell S, Langton C, Al-Obaidi MJ, Oblak M, Salek S. Goswami P, et al. Among authors: al ismail s. J Comp Eff Res. 2019 May;8(7):523-533. doi: 10.2217/cer-2018-0108. Epub 2019 Apr 30. J Comp Eff Res. 2019. PMID: 31037971 Free article. Clinical Trial.
Erythropoiesis and iron metabolism in Hodgkin's disease.
Al-Ismail S, Cavill I, Evans IH, Jacobs A, Ricketts C, Trevett D, Whittaker JA. Al-Ismail S, et al. Br J Cancer. 1979 Sep;40(3):365-70. doi: 10.1038/bjc.1979.190. Br J Cancer. 1979. PMID: 508565 Free PMC article.
37 results